Term: Drug Program Information Network (DPIN) Database

Printer friendly

Glossary Definition

Last Updated: 2008-02-14

Definition:

A database containing prescription drug claims from the Drug Programs Information Network (DPIN), an electronic, on-line, point-of-sale prescription drug database. Initiated in 1994, it connects Manitoba Health and all pharmacies in Manitoba to a central database maintained by Manitoba Health. Information about pharmaceutical dispensations is captured in real time for all Manitoba residents (including Registered First Nations), regardless of insurance coverage or final payer. DPIN facilitates payment administration for eligible drug costs, incorporating functions such as real-time adjudication, and collects high-quality data on all prescriptions issued to Manitobans, such as drug, dosage, and prescription date. Note that the prescription's indication (the physician's prescribing intent) is not collected and must be inferred from other data.

Related concepts 

• Calculating Costs/Expenditures for Pharmaceuticals
• Hormone Replacement Therapy (HRT) Use
• Mental Health Disorder / Illness Classification

Related terms 

• Dispensed Medications
• Drug Identification Number (DIN) Master File
• End of life Prescription Drugs
• Index Date (Drugs)
• Master (Common) Formulary
• Pharmaceutical Use
• Prescribed Days Supplied
• Prescription Cost
• Prescriptions

Links 

• MCHP Data Repository - Drug Program Information Network (DPIN) Database

Term used in 

• Bernstein CN, Blanchard JF, Metge C, Yogendran M. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer? Am J Gastroenterol 2003;98(12):2784-2788. [Abstract] (View)
• Bernstein CN, Blanchard JF, Metge C, Yogendran M. The association between corticosteroid use and development of fractures among IBD patients in a population-based database. Am J Gastroenterol 2003;98(8):1797-1801. [Abstract] (View)
• Doupe M, Kozyrskyj A, Soodeen R, Derksen S, Burchill C, Huq S. An Initial Analysis of Emergency Departments and Urgent Care in Winnipeg. Winnipeg, MB: Manitoba Centre for Health Policy, 2008. [Full Report] [Summary] [Data extras] (View)
• Doupe M, Brownell M, Kozyrskyj A, Dik N, Burchill C, Dahl M, Chateau D, De Coster C, Hinds A, Bodnarchuk J. Using Administrative Data to Develop Indicators of Quality Care in Personal Care Homes. Winnipeg, MB: Manitoba Centre for Health Policy, 2006. [Full Report] [Summary] [Data extras] (View)
• Fransoo R, Martens P, Burland E, The Need to Know Team, Prior H, Burchill C. Manitoba RHA Indicators Atlas 2009. Winnipeg, MB: Manitoba Centre for Health Policy, 2009. [Full Report] [Summary] [Data extras] (View)
• Katz A, Bogdanovic B, Ekuma O, Soodeen RA, Chateau D, Burnett C. Physician Resource Projection Models . Winnipeg, MB: Manitoba Centre for Health Policy, 2009. [Full Report] [Summary] (View)
• Katz A, De Coster C, Bogdanovic B, Soodeen R, Chateau D. Using Administrative Data to Develop Indicators of Quality in Family Practice. Winnipeg, MB: Manitoba Centre for Health Policy, 2004. [Full Report] [Summary] (View)
• Kozyrskyj A, Lix L, Dahl M, Soodeen R. High-cost Users of Pharmaceuticals: Who are They? Winnipeg, MB: Manitoba Centre for Health Policy, 2005. [Full Report] [Summary] (View)
• Martens P, Fransoo R, The Need to Know Team, Burland E, Prior H, Burchill C, Romphf L, Chateau D, Bailly A, Ouelette C. What Works? A First Look at Evaluating Manitoba's Regional Health Programs and Policies at the Population Level. Winnipeg, MB: Manitoba Centre for Health Policy, 2008. [Full Report] [Summary] [Data extras] (View)
• Metge C, Black C, Peterson S, Kozyrskyj A, Roos NP, Bogdanovic B. Analysis of Patterns of Pharmaceutical Use in Manitoba, 1996: Key Findings - A POPULIS Project. Winnipeg, MB: Manitoba Centre for Health Policy and Evaluation, 1999. [Full Report] [Summary] (View)
• Metge C, Chateau D, Prior H, Soodeen R, De Coster C, Barre L. Composite Measures/Indices of Health and Health System Performance. Winnipeg, MB: Manitoba Centre for Health Policy, 2009. [Full Report] [Summary] (View)
• Metge C, Kozyrskyj A, Dahl M, Yogendran M, Roos NP. Pharmaceuticals: Focussing on Appropriate Utilization. Winnipeg, MB: Manitoba Centre for Health Policy, 2003. [Full Report] [Summary] (View)
• Metge CJ, Blanchard JF, Peterson S, Bernstein CN. Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study. Am J Gastroenterol 2001;96(12):3348-3355. [Abstract] (View)